On July 15, 2021, the Board of Directors of Cannabics Pharmaceuticals Inc. appointed Dr. Gil Feiler as an Independent Board Member, joining Dr. Inbar Maymon Pomeranchik. Dr. Gil Feiler brings over 25 years of executive experience of the highest caliber, is a Director of the Bank of Georgia, formerly Board member of First International Bank of Israel, advisor for the government of Ras Al Khaimah, UAE, Alumni of the US State Dept International Visitor Leadership Program, as well as known author of numerous publications on regional economics and business relations.